- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04965974
Efficacy of Blue Wavelength in Managing Dry Eye
July 16, 2021 updated by: Shumaila Masood, University of Faisalabad
The study is conducted to evaluate the efficacy of digital blue light blocking filter in improvement of clinical indices of dry eye and ocular symptoms related to dry eye.
Introduction: Dry eye disease is a multifactorial disease of the ocular surface caused by loss of tear film homeostasis resulting damage to the ocular surface and neurosensory abnormalities.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
60 subjects aged 20-35 years with ocular surface disease index score greater than 13 will be taken from the University of Faisalabad.
After taking consent, procedure starts from history then Schirmer test 1 will be performed to measure the tear deficient dry eye.
Tear break up time will be done to assess the evaporative dry eye.
Corneal surface staining will be used to measure corneal erosions.
OSDI questionnaire will be used for the evaluation of ocular symptoms related to dry eye.
The digital blue light blocking filter will be randomly installed in digital devices of the 80 subjects and rest of 80 will be without filter.
After baseline data follow ups will be after 3 weeks and second after 8 weeks of filter use.
Schirmer test 1, tear break up time corneal surface staining and OSDI will be performed on both groups (filter users and non-filter users) for the evaluation of dry eye.
Data will be analyzed using SPSS version 21.
Result of this study will give knowledge that use of digital blue light blocking filters are useful in the management of dry eye disease.
Study Type
Interventional
Enrollment (Anticipated)
160
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Komal Atta, MBBS
- Phone Number: 03224075007
- Email: komal.atta@tuf.edu.pk
Study Contact Backup
- Name: Nimra Gul, m.phil od
- Phone Number: 03156673622
- Email: Nimra.gul@tuf.edu.pk
Study Locations
-
-
Punjab Pakistan
-
Faisalābad, Punjab Pakistan, Pakistan, 38000
- The University of Faisalabad
-
Contact:
- Komal Atta, MBBS
- Phone Number: 03224075007
- Email: komal.atta@tuf.edu.pk
-
Contact:
- Nimra Gul, M.phil
- Phone Number: 0315 66773622
- Email: Nimra.gul@tuf.edu.pk
-
Principal Investigator:
- Shumaila Masood, M.phil
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Females with age 20-35years
- using digital devices androids and laptops
- Ametropia of up to 1.0 Diopter sphere(DS) and astigmatism of less than 0.5
- Emmetropes.
Exclusion Criteria:
- Subjects using topical drugs
- Smokers
- Subjects undergoing dry eye treatment
- History of contact lens wear within the past three months
- Corneal surface disease other than dry eye
- Corneal or eyelid infections
- Corneal surgeries
- Refractive error of more than 1 DS of SE and astigmatism of greater than0.5DC
- Age <18 and >3 years
- Subjects already using blue light blocking filters
- I phone users
- Pregnant women
- Males
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1 blue light blocking filter group
digital blue light blocking filter is installed laptops and mobile phones of 80 individual using digital devices more than 4 hours.
asked them to use the filter continuously while using digital devices.
|
digital blue light blocking filter will be given to 80 dry eye subjects in mobile phones and laptops and 80 individuals will be without filters digital devices users
Other Names:
|
Experimental: 2 non filter users
Effect of time duration of digital screen on the dry eyes is checked.
|
digital blue light blocking filter will be given to 80 dry eye subjects in mobile phones and laptops and 80 individuals will be without filters digital devices users
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
tear break up time
Time Frame: 8 weeks
|
improvement in evaporative dry eye will be assessed by improvement in tear break up time in seconds after filter use.
|
8 weeks
|
Schirmer test values
Time Frame: 8 weeks
|
improvement in aqueous deficient dry eye by Schirmer test values in mm .
|
8 weeks
|
corneal surface staining
Time Frame: 8 weeks
|
'corneal surface staining grade scale' assess the improvement corneal surface erosions after filter use
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ocular surface disease index questionnaire
Time Frame: 8 weeks
|
improvement in ocular surface disease index score.13-22ocular
surface disease index score mild dry eye ,23-32 score means moderate dry eye and ocular surface disease index greater than 33 indicate severe dry eye .
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 1, 2021
Primary Completion (Anticipated)
July 1, 2021
Study Completion (Anticipated)
August 1, 2021
Study Registration Dates
First Submitted
June 10, 2021
First Submitted That Met QC Criteria
July 8, 2021
First Posted (Actual)
July 16, 2021
Study Record Updates
Last Update Posted (Actual)
July 23, 2021
Last Update Submitted That Met QC Criteria
July 16, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- TUF/MPO/2101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dry Eye Disease
-
Bausch & Lomb IncorporatedCompletedDry Eye Disease (DED)United States
-
Gordon Schanzlin New VisionCompletedDry Eye | Dry Eye Disease | Evaporative Dry Eye | Kerato Conjunctivitis Sicca | Evaporative Dry Eye Disease | Dry Eye, EvaporativeUnited States
-
Laboratorios Sophia S.A de C.V.Not yet recruitingOcular Surface Disease | Dry Eye Disease | Dry Eye Sensation
-
Senju Pharmaceutical Co., Ltd.CompletedDry Eye Syndrome | Dry Eye DiseaseUnited States
-
AllerganCompletedDry Eye Syndrome | Dry Eye DiseaseUnited States
-
LantibioRiver Plate Biotechnology, Inc.; Rx Development Resources, LLCCompletedSafety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye SyndromeDry Eye DiseaseUnited States
-
Fundación Oftalmológica Los AndesAlcon ResearchNot yet recruitingCataract | Dry Eye Syndrome | Dry Eye Disease | Phacoemulsification | Evaporative Dry Eye
-
Vienna Institute for Research in Ocular SurgeryTerminated
-
Novaliq GmbHCompletedDry Eye Disease (DED)United States
-
Novaliq GmbHCompletedDry Eye Disease (DED)United States
Clinical Trials on Digital blue light blocking filter
-
University of Alabama at BirminghamCompletedAttention Deficit Hyperactivity Disorder | Delayed Sleep Phase Type Circadian Rhythm Sleep DisorderUnited States
-
West Virginia UniversityRecruitingCircadian Rhythm DisordersUnited States
-
University of RzeszowCompletedNerve Disorders
-
Universiteit LeidenEindhoven University of Technology; Geestelijke Gezondheidszorg Eindhoven (GGzE) and other collaboratorsNot yet recruitingDepression, Unipolar | Depression, BipolarNetherlands
-
Columbia UniversityNational Institute on Aging (NIA)Active, not recruitingInsomnia | Sleep Disturbance | Acute Coronary SyndromeUnited States
-
University of PittsburghNational Institute of Mental Health (NIMH)RecruitingDepression in Adolescence | Depression in AdultsUnited States
-
The Hong Kong Polytechnic UniversityCompletedEffects of Blue-light Blocking Lens on Visual Functions
-
Shanghai Zhongshan HospitalFudan University; Shanghai Mental Health Center, Jingan District; Shanghai Mental...Unknown
-
University of PittsburghWithdrawn
-
Chang Gung Memorial HospitalRecruitingDelirium | Circadian DysrhythmiaTaiwan